agilon health, inc. (NYSE:AGL) Given Consensus Recommendation of “Reduce” by Analysts

Shares of agilon health, inc. (NYSE:AGL) have earned a consensus rating of “Reduce” from the twenty analysts that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $6.05.

AGL has been the topic of a number of recent research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft cut their target price on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. TD Cowen dropped their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Barclays dropped their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Finally, Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd.

Insider Transactions at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 42.03 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the last quarter. State Street Corp increased its holdings in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares during the last quarter. Geode Capital Management LLC increased its holdings in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares during the last quarter. Citigroup Inc. increased its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter.

agilon health Price Performance

Shares of AGL opened at $2.10 on Friday. agilon health has a 12-month low of $1.50 and a 12-month high of $13.76. The business’s fifty day moving average is $2.76 and its 200 day moving average is $4.66. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market cap of $865.24 million, a P/E ratio of -2.23 and a beta of 0.60.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Sell-side analysts anticipate that agilon health will post -0.47 earnings per share for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.